AZD7325 + Radioligand (11C) flumazenil
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anxiety
Conditions
Anxiety
Trial Timeline
Feb 1, 2008 → Jul 1, 2008
NCT ID
NCT00681720About AZD7325 + Radioligand (11C) flumazenil
AZD7325 + Radioligand (11C) flumazenil is a phase 1 stage product being developed by AstraZeneca for Anxiety. The current trial status is completed. This product is registered under clinical trial identifier NCT00681720. Target conditions include Anxiety.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00681720 | Phase 1 | Completed |
Competing Products
20 competing products in Anxiety